>북미 비듬 치료 시장, 유형별(진균성 비듬, 건성 피부 관련 비듬, 지성 두피 관련 비듬, 질병 관련 비듬), 처방 방식(OTC, 처방), 제품(비의료적, 약물적), 약물 유형(브랜드, 제네릭), 연령대(성인, 소아과, 신생아), 성별(남성, 여성), 최종 사용자(홈케어, 피부과 센터, 전문 병원, 기타), 유통 유형(슈퍼마켓/하이퍼마켓, 편의점, 약국, 소매점, 온라인 매장, 기타), 국가별(미국, 캐나다, 멕시코) 산업 동향 및 2028년까지의 예측
시장 분석 및 통찰력: 북미 비듬 치료 시장
비듬 치료 시장은 2021년부터 2028년까지의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 시장이 2021년부터 2028년까지의 예측 기간 동안 5.8%의 CAGR로 성장하고 있으며 2028년까지 1,191만 5,150만 달러에 도달할 것으로 예상한다고 분석합니다. 두피 상태에 대한 인식 증가와 제품 가용성은 비듬 치료 시장의 주요 동인으로 작용합니다.
비듬은 클러스터를 형성할 수 있는 각질세포의 존재로 식별되는 두피 장애입니다. 이러한 클러스터는 흰색에서 황색 비늘을 가지고 있으며 영향을 받는 부위에 가려움을 유발합니다. 비듬은 주로 사춘기 에서 중년기에 영향을 미치는데, 이 시기는 피지선이 매우 활동적인 단계이기 때문입니다. 비듬과 관련된 다양한 원인이 있으며, 곰팡이인 말라세지아 푸르푸르가 지배적인 요인이 됩니다. 게다가 두피 위의 박테리아 성장은 두피 각질층을 손상시킵니다.
환경에서 말라세지아 종의 수가 증가함에 따라 비듬 치료 시장이 성장하고 있습니다. 다양한 비듬 치료 대체제의 가용성은 비듬 치료 시장이 성장하는 데 제약이 됩니다. 혁신적인 제품의 도입은 비듬 치료 시장이 성장하는 데 기회가 됩니다. 비듬 방지 제품의 리콜은 비듬 치료 시장이 성장하는 데 도전이 됩니다.
비듬 치료 시장 보고서는 시장 점유율, 새로운 개발 및 제품 파이프라인 분석, 국내 및 지역 시장 참여자의 영향, 새로운 수익 주머니, 시장 규정의 변화, 제품 승인, 전략적 의사 결정, 제품 출시, 지리적 확장 및 시장의 기술 혁신 측면에서의 분석 기회에 대한 세부 정보를 제공합니다. 분석 및 비듬 치료 시장 시나리오를 이해하려면 Data Bridge Market Research에 연락하여 분석가 브리핑을 요청하세요. 당사 팀은 원하는 목표를 달성하기 위한 수익 영향 솔루션을 만드는 데 도움을 드립니다.
비듬 치료 시장 범위 및 시장 규모
The dandruff treatment market is categorized into eight notable segments which are based on the type, mode of prescription, product, drug type, age group, gender, end user and distribution type. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of type, the dandruff treatment market is segmented into fungal dandruff, dry skin-related dandruff, oily scalp-related dandruff, disease related dandruff. In 2021, fungal dandruff segment is dominating as a fungus called Malassezia is considered to be the main cause of dandruff. Although dandruff can be caused by several simultaneous reasons, the level of a fungus is one of the strongest contributing factors. A large number of dandruff treatment products aim at restoring the microbiome of scalp and hence controlling the fungus
- On the basis of mode of prescription, the dandruff treatment market is segmented into OTC and prescription. In 2021, OTC segment is dominating as most of the dandruff treatment products can be used at home without any prescription. These products are used over the skin and do not enter the body, making them safe for self-supervision. The easy availability of these products also attribute to the high share of OTC products in the dandruff treatment market.
- On the basis of product, the dandruff treatment market is segmented into non-medicated and medicated. In 2021, non-medicated segment is dominating as more than 50% of adults are affected by this transient condition that does not cause any significant medical conditions. Most of the products for dandruff treatment are available over-the-counter and prove effective in controlling the symptoms.
- On the basis of drug type, the dandruff treatment market is segmented into branded and generics. In 2021, branded segment is dominating as most of the products constitute shampoos and oils manufactured by well-known global companies. Due to significant product promotion, consumer awareness is very high for several products making the branded products more common.
- On the basis of age group, the dandruff treatment market is segmented into adults, paediatrics and neonates. In 2021, adults segment is dominating as the dandruff effects 50% of adults over different time period primary due to fungus infection, dry scalp and sebum production. Moreover the number of adults affected by dandruff is very high as compared to paediatrics and neonates. Hence, adults are the primary users of dandruff treatment products.
- 성별에 따라 비듬 치료 시장은 남성과 여성 으로 세분화됩니다 . 2021년에는 남성 세그먼트가 우세한데, 곰팡이와 건조함 외에도 피지 수치가 더 높아서 비듬과 관련이 있기 때문입니다. 따라서 여성에 비해 남성이 비듬에 더 많이 영향을 받습니다. 이는 청소년기에 피지 생성이 급증하는 등 피부의 피지선(오일) 활동이 변하기 때문에 발생할 가능성이 높아지기 때문일 수 있습니다.
- 최종 사용자를 기준으로 비듬 치료 시장은 홈케어 , 피부과 센터, 전문 병원 및 기타로 세분화됩니다. 2021년에는 대부분 제품의 자가 관리 특성으로 인해 홈케어 부문이 지배적입니다. 증상은 쉽게 알아볼 수 있고 의학적으로 해롭지 않습니다. 따라서 영향을 받은 개인은 대부분의 경우 스스로를 돌보는 경향이 있습니다.
- 유통 유형에 따라 비듬 치료 시장은 슈퍼마켓/하이퍼마켓, 편의점, 약국, 소매점, 온라인 매장 등으로 세분화됩니다. 2021년에는 슈퍼마켓/하이퍼마켓 부문이 소비자 제품의 가장 높은 매출을 올리는 출처로 우세합니다. 이러한 시설에는 가장 간단한 제품부터 고급 제품까지 다양한 비듬 치료 제품이 있으며 소비자는 요구 사항에 따라 선택할 수 있습니다. 결과적으로 소비자는 선택의 폭이 넓어 슈퍼마켓/하이퍼마켓을 선호합니다.
비듬 치료 시장 국가 수준 분석
비듬 치료 시장을 분석하고, 위에 언급된 대로 국가, 유형, 처방 방식, 제품, 약물 유형, 연령대, 성별, 최종 사용자 및 유통 유형별로 시장 규모 정보를 제공합니다.
북미 비듬 치료 시장 보고서에서 다루는 국가는 미국, 캐나다, 멕시코입니다.
북미 지역은 비듬 치료 시장에서 대부분 점유율을 차지하고 있으며, 환경 내 말라세지아 종의 증가, HIV 유병률 증가로 인해 예측 기간 동안 CAGR을 보일 것으로 예상됩니다. 미국은 세계에서 가계 지출이 가장 많고 여러 국가와 무역 협정을 맺고 있어 비듬 치료 제품을 포함한 소비자 제품의 가장 큰 시장입니다.
보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 신규 판매, 교체 판매, 국가 인구 통계, 규제 조치 및 수출입 관세와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 주요 포인터 중 일부입니다. 또한 글로벌 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 판매 채널의 영향은 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.
제조업체의 전략적 이니셔티브는 비듬 치료 시장의 플레이어에게 새로운 기회를 창출하고 있습니다.
비듬 치료 시장은 또한 비듬 치료 제품 판매의 모든 국가별 성장, 비듬 치료 발전의 영향, 비듬 치료 시장에 대한 지원과 함께 규제 시나리오의 변화에 대한 자세한 시장 분석을 제공합니다. 이 데이터는 2010년부터 2019년까지의 과거 기간에 대해 제공됩니다.
경쟁 환경 및 비듬 치료 시장 점유율 분석
비듬 치료 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 생산 현장 및 시설, 회사의 강점과 약점, 제품 출시, 제품 시험 파이프라인, 제품 승인, 특허, 제품 폭과 폭, 응용 분야 우세, 기술 수명선 곡선입니다. 위에 제공된 데이터 포인트는 비듬 치료 시장과 관련된 회사의 초점에만 관련이 있습니다.
비듬 치료제를 제공하는 주요 기업으로는 Alliance Pharma PLC, Arcadia Consumer Healthcare, Vyome Therapeutics Inc., Henkel AG & Co. KGaA, L'ORÉAL, Sovereign Chemicals & Cosmetics, ACTICON LIFE SCIENCES, John Paul Mitchell Systems, Johnson & Johnson Consumer Inc.(Johnson & Johnson Services, Inc.의 자회사), JASÖN Natural Products, Inc.(Hain Celestial의 자회사), Cipla Inc., PHYTO, Dabur, Glenmark Pharmaceuticals Limited, Kao Corporation, L'OCCITANE EN PROVENCE INTERNATIONAL SA(Groupe L'OCCITANE의 자회사), Procter & Gamble, Philip Kingsley Products Ltd., Unilever 등이 있으며, 국내 및 글로벌 기업도 있습니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁사에 대한 경쟁 분석을 별도로 제공합니다.
또한 전 세계 여러 회사에서 많은 제품 출시와 계약을 체결하면서 비듬 치료 시장도 활성화되고 있습니다.
예를 들어,
- 2020년 9월, Henkel AG & Co. KGaA의 브랜드 Syoss는 헤어케어 라인에서 살롱 전문성을 재출시했습니다. 이 헤어케어 라인은 새로운 포뮬러와 샴푸 병과 함께 출시되었습니다. 이 제품 출시는 회사가 다양한 지리적 지역에 침투하여 시장 점유율을 높이는 데 도움이 될 것입니다.
- 2020년 7월, Johnson & Johnson Consumer Inc.(Johnson &Johnson Services, Inc.의 자회사)는 Neutrogena Healthy Scalp Collection을 출시하여 헤어케어 제품 포트폴리오를 확장했습니다. 이 헤어케어 확장은 Neutrogena와 Vogue International의 헤어케어 전문가 간의 Johnson & Johnson Services, Inc. 내부 협업을 통해 개발되었습니다.
협력, 합작투자 및 기타 시장 참여자 전략은 비듬 치료 시장에서 회사 시장을 확대하고 있으며, 이를 통해 기업은 비듬 치료에 대한 제공 서비스를 개선하는 데에도 도움이 됩니다.
SKU-
세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요
- 대화형 데이터 분석 대시보드
- 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
- 사용자 정의 및 질의를 위한 리서치 분석가 액세스
- 대화형 대시보드를 통한 경쟁자 분석
- 최신 뉴스, 업데이트 및 추세 분석
- 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
목차
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA DANDRUFF TREATMENT MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 REGULATORY SCENARIO FOR DANDRUFF TREATMENT
4.1.1 JAPAN REGULATORY SCENARIO FOR DANDRUFF TREATMENT
4.1.2 CHINA REGULATORY SCENARIO FOR DANDRUFF TREATMENT
4.1.3 EUROPEAN REGULATORY SCENARIO FOR DANDRUFF TREATMENT
5 EPIDEMIOLOGY
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASING NUMBER OF MALASSEZIA SPECIES IN ENVIRONMENT
6.1.2 INCREASING PREVALENCE OF HIV
6.1.3 RISING AWARENESS REGARDING THE TARGET DISEASE
6.1.4 INCREASING LEVEL OF STRESS
6.1.5 CHANGING LIFESTYLE AND GROWING URBANIZATION
6.2 RESTRAINTS
6.2.1 INCREASING ADOPTION OF NO-POO CAMPAIGN
6.2.2 AVAILABILITY OF VARIOUS DANDRUFF TREATMENT SUBSTITUES
6.2.3 SIDE EFFECTS OF DANDRUFF TREATMENT PRODUCTS
6.3 OPPORTUNITIES
6.3.1 INTRODUCTION OF INNOVATIVE PRODUCTS
6.3.2 STRATEGIC INITIATIVES BY MARKET PLAYERS
6.3.3 INCREASING E-COMMERCE OF HAIR CARE PRODUCTS
6.3.4 RISING DISPOSABLE INCOME
6.4 CHALLENGES
6.4.1 PRODUCT RECALL
6.4.2 INCREASING PREVALENCE OF COVID-19
6.4.3 ENVIRONMENTAL ISSUES WITH SHAMPOOS BOTTLE DISPOSAL
7 COVID-19 IMPACT ON NORTH AMERICA DANDRUFF TREATMENT MARKET
7.1 PRICE IMPACT
7.2 IMPACT ON DEMAND
7.3 IMPACT ON SUPPLY CHAIN
7.4 STRATEGIC DECISIONS FOR MANUFACTURERS
7.5 CONCLUSION
8 NORTH AMERICA DANDRUFF TREATMENT MARKET, BY TYPE
8.1 OVERVIEW
8.2 FUNGAL DANDRUFF
8.3 DRY SKIN-RELATED DANDRUFF
8.4 OILY SCALP-RELATED DANDRUFF
8.5 DISEASE RELATED DANDRUFF
9 NORTH AMERICA DANDRUFF TREATMENT MARKET, BY MODE OF PRESCRIPTION
9.1 OVERVIEW
9.2 OTC
9.3 PRESCRIPTION
10 NORTH AMERICA DANDRUFF TREATMENT MARKET, BY PRODUCT
10.1 OVERVIEW
10.2 NON- MEDICATED
10.2.1 SHAMPOO
10.2.1.1 Anti- Dandruff Shampoo
10.2.1.1.1 Neem
10.2.1.1.2 Tea Tree
10.2.1.1.3 Reetha
10.2.1.1.4 Jujube Bark Extract
10.2.1.1.5 Coconut
10.2.1.1.6 Hibiscus
10.2.1.1.7 Others
10.2.1.2 Normal Shampoo
10.2.1.2.1 Normal Hair Shampoo
10.2.1.2.2 Oily Hair Shampoo
10.2.1.2.3 Dry, Damaged Hair Shampoo
10.2.1.2.4 Volumizing Shampoo
10.2.1.2.5 Others
10.2.2 OILS
10.2.2.1 Coconut Oil
10.2.2.2 Eucalyptus
10.2.2.3 Lemon Oil
10.2.2.4 Sunflower
10.2.2.5 Almond Oil
10.2.2.6 Argan Oil
10.2.2.7 Others
10.2.3 SERUM
10.2.3.1 Tea Tree
10.2.3.2 Eucalyptus
10.2.3.3 Piroctone Olamine
10.2.3.4 Camphor
10.2.3.5 Peppermint
10.2.3.6 Basil & Cedarwood
10.2.3.7 Rosemary
10.2.3.8 Lemon
10.2.3.9 Others
10.2.4 HAIR MASK
10.2.4.1 Tea Tree Oil
10.2.4.2 Lemon Oil
10.2.4.3 Argan Oil
10.2.4.4 Others
10.2.5 OTHERS
10.3 MEDICATED
10.3.1 SHAMPOO
10.3.1.1 Anti-Dandruff Shampoos
10.3.1.1.1 Pyrithione Zinc Shampoos(Dermazinc, Head & Shoulders, Jason Dandruff Relief 2 in 1, Others)
10.3.1.1.2 Selenium Sulfide Shampoos (Head & Shoulders Intensive, Selsun Blue, Others)
10.3.1.1.3 Shampoos Containing Salicylic Acid (Neutrogena T/Sal Shampoo, Baker's P & S, Others)
10.3.1.1.4 Ketoconazole Shampoos (Nizoral A-D, Extina, Others)
10.3.1.1.5 Tar-Based Shampoos (Neutrogena T/Gel, Scytera, Others)
10.3.1.1.6 Others
10.3.1.2 Normal Shampoos
10.3.1.2.1 Normal Hair Shampoos
10.3.1.2.2 Oily Hair Shampoos
10.3.1.2.3 Dry, Damaged Hair Shampoo
10.3.1.2.4 Volumizing Shampoo
10.3.1.2.5 Others
10.3.2 DRY SHAMPOOS
10.3.2.1 Denatured Alcohol
10.3.2.2 Magnesium Stearate
10.3.2.3 Laminaria Saccharina Extract
10.3.2.4 Others
11 NORTH AMERICA DANDRUFF TREATMENT MARKET, BY DRUG TYPE
11.1 OVERVIEW
11.2 BRANDED
11.3 GENERICS
12 NORTH AMERICA DANDRUFF TREATMENT MARKET, BY AGE GROUP
12.1 OVERVIEW
12.2 ADULTS
12.3 PEDIATRICS
12.4 NEONATES
13 NORTH AMERICA DANDRUFF TREATMENT MARKET, BY GENDER
13.1 OVERVIEW
13.2 MALE
13.3 FEMALE
14 NORTH AMERICA DANDRUFF TREATMENT MARKET, BY END USER
14.1 7.1 OVERVIEW
15 NORTH AMERICA DANDRUFF TREATMENT MARKET, BY DISTRIBUTION TYPEE
15.1 OVERVIEW
15.2 SUPERMARKETS /HYPERMARKETS
15.3 CONVENIENCE STORES
15.4 PHARMACIES
15.5 RETAIL STORES
15.6 ONLINE STORES
15.7 OTHERS
16 NORTH AMERICA DANDRUFF TREATMENT MARKET, BY GEOGRAPHY
16.1 NORTH AMERICA
16.1.1 U.S.
16.1.2 CANADA
16.1.3 MEXICO
17 NORTH AMERICA DANDRUFF TREATMENT MARKET: COMPANY LANDSCAPE
17.1 NORTH AMERICA DANDRUFF TREATMENT MARKET, COMPANY LANDSCAPE
17.1.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
17.2 EUROPE DANDRUFF TREATMENT MARKET, COMPANY LANDSCAPE
17.2.1 COMPANY SHARE ANALYSIS: EUROPE
17.3 ASIA-PACIFIC DANDRUFF TREATMENT MARKET, COMPANY LANDSCAPE
17.3.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
18 SWOT ANALYSIS
19 COMPANY PROFILES
19.1 PROCTER & GAMBLE
19.1.1 COMPANY SNAPSHOT
19.1.2 REVENUE ANALYSIS
19.1.3 COMPANY SHARE ANALYSIS
19.1.4 PRODUCT PORTFOLIO
19.1.5 RECENT DEVELOPMENT
19.2 UNILEVER
19.2.1 COMPANY SNAPSHOT
19.2.2 REVENUE ANALYSIS
19.2.3 COMPANY SHARE ANALYSIS
19.2.4 PRODUCT PORTFOLIO
19.2.5 RECENT DEVELOPMENTS
19.3 L'ORÉAL
19.3.1 COMPANY SNAPSHOT
19.3.2 REVENUE ANALYSIS
19.3.3 COMPANY SHARE ANALYSIS
19.3.4 PRODUCT PORTFOLIO
19.3.5 RECENT DEVELOPMENTS
19.4 KAO CORPORATION
19.4.1 COMPANY SNAPSHOT
19.4.2 REVENUE ANALYSIS
19.4.3 COMPANY SHARE ANALYSIS
19.4.4 PRODUCT PORTFOLIO
19.4.5 RECENT DEVELOPMENT
19.5 JOHNSON & JOHNSON CONSUMER INC. (A SUBSIDIARY OF JOHNSON & JOHNSON SERVICES, INC.)
19.5.1 COMPANY SNAPSHOT
19.5.2 REVENUE ANALYSIS
19.5.3 COMPANY SHARE ANALYSIS
19.5.4 PRODUCT PORTFOLIO
19.5.5 RECENT DEVELOPMENT
19.6 ACTICON LIFE SCIENCES
19.6.1 COMPANY SNAPSHOT
19.6.2 PRODUCT PORTFOLIO
19.6.3 RECENT DEVELOPMENT
19.7 ALLIANCE PHARMA PLC
19.7.1 COMPANY SNAPSHOT
19.7.2 REVENUE ANALYSIS
19.7.3 PRODUCT PORTFOLIO
19.7.4 RECENT DEVELOPMENTS
19.8 ARCADIA CONSUMER HEALTHCARE
19.8.1 COMPANY SNAPSHOT
19.8.2 PRODUCT PORTFOLIO
19.8.3 RECENT DEVELOPMENTS
19.9 ARION HEALTHCARE
19.9.1 COMPANY SNAPSHOT
19.9.2 PRODUCT PORTFOLIO
19.9.3 RECENT DEVELOPMENT S
19.1 CIPLA INC.
19.10.1 COMPANY SNAPSHOT
19.10.2 REVENUE ANALYSIS
19.10.3 PRODUCT PORTFOLIO
19.10.4 RECENT DEVELOPMENT
19.11 DABUR
19.11.1 COMPANY SNAPSHOT
19.11.2 REVENUE ANALYSIS
19.11.3 PRODUCT PORTFOLIO
19.11.4 RECENT DEVELOPMENT
19.12 GLENMARK PHARMACEUTICALS LIMITED
19.12.1 COMPANY SNAPSHOT
19.12.2 REVENUE ANALYSIS
19.12.3 PRODUCT PORTFOLIO
19.12.4 RECENT DEVELOPMENT
19.13 HENKEL AG & CO. KGAA
19.13.1 COMPANY SNAPSHOT
19.13.2 REVENUE ANALYSIS
19.13.3 PRODUCT PORTFOLIO
19.13.4 RECENT DEVELOPMENTS
19.14 JĀSÖN® NATURAL PRODUCTS, INC. (A SUBSIDIARY OF HAIN CELESTIAL)
19.14.1 COMPANY SNAPSHOT
19.14.2 REVENUE ANALYSIS
19.14.3 PRODUCT PORTFOLIO
19.14.4 RECENT DEVELOPMENT
19.15 JOHN PAUL MITCHELL SYSTEMS
19.15.1 COMPANY SNAPSHOT
19.15.2 PRODUCT PORTFOLIO
19.15.3 RECENT DEVELOPMENTS
19.16 L'OCCITANE EN PROVENCE INTERNATIONAL SA. (A SUBSIDIARY OF GROUPE L'OCCITANE)
19.16.1 COMPANY SNAPSHOT
19.16.2 REVENUE ANALYSIS
19.16.3 PRODUCT PORTFOLIO
19.16.4 RECENT DEVELOPMENTS
19.17 M.M. AYURVEDIC (P) LTD.
19.17.1 COMPANY SNAPSHOT
19.17.2 PRODUCT PORTFOLIO
19.17.3 RECENT DEVELOPMENT
19.18 NIKOLE KOZMETICS
19.18.1 COMPANY SNAPSHOT
19.18.2 PRODUCT PORTFOLIO
19.18.3 RECENT DEVELOPMENT
19.19 PHILIP KINGSLEY PRODUCTS LTD.
19.19.1 COMPANY SNAPSHOT
19.19.2 PRODUCT PORTFOLIO
19.19.3 RECENT DEVELOPMENTS
19.2 PHYTO
19.20.1 COMPANY SNAPSHOT
19.20.2 PRODUCT PORTFOLIO
19.20.3 RECENT DEVELOPMENT
19.21 SEBAPHARMA GMBH & CO. KG
19.21.1 COMPANY SNAPSHOT
19.21.2 PRODUCT PORTFOLIO
19.21.3 RECENT DEVELOPMENT
19.22 SOVEREIGN CHEMICALS & COSMETICS
19.22.1 COMPANY SNAPSHOT
19.22.2 PRODUCT PORTFOLIO
19.22.3 RECENT DEVELOPMENT
19.23 VYOME THERAPEUTICS INC.
19.23.1 COMPANY SNAPSHOT
19.23.2 PRODUCT PORTFOLIO
19.23.3 RECENT DEVELOPMENTS
19.24 VIENCEE PHARMA SCIENCE
19.24.1 COMPANY SNAPSHOT
19.24.2 PRODUCT PORTFOLIO
19.24.3 RECENT DEVELOPMENT
20 QUESTIONNAIRE
21 RELATED REPORTS
표 목록
LIST OF TABLES
TABLE 1 NORTH AMERICA DANDRUFF TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 2 NORTH AMERICA FUNGAL DANDRUFF IN DANDRUFF TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 3 NORTH AMERICA DRY SKIN-RELATED DANDRUFF IN DANDRUFF TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 4 NORTH AMERICA OILY SCALP-RELATED IN DANDRUFF TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 5 NORTH AMERICA DISEASE RELATED IN DANDRUFF TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 6 NORTH AMERICA DANDRUFF TREATMENT MARKET, BY MODE OF PRESCRIPTION, 2019-2028 (USD MILLION)
TABLE 7 NORTH AMERICA OVER-THE-COUNTER IN DANDRUFF TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 8 NORTH AMERICA PRESCRIPTION IN DANDRUFF TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 9 NORTH AMERICA DANDRUFF TREATMENT MARKET, BY TYPE, 2018-2028 (USD MILLION)
TABLE 10 NORTH AMERICA NON- MEDICATED IN DANDRUFF TREATMENT MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 11 NORTH AMERICA NON-MEDICATED IN DANDRUFF TREATMENT MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 12 NORTH AMERICA SHAMPOO IN DANDRUFF TREATMENT MARKET (NON-MEDICATED), BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 13 NORTH AMERICA ANTI-DANDRUFF SHAMPOOS IN DANDRUFF TREATMENT MARKET (NON-MEDICATED), BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 14 NORTH AMERICA NORMAL SHAMPOOS IN DANDRUFF TREATMENT MARKET (NON-MEDICATED), BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 15 NORTH AMERICA OILS IN DANDRUFF TREATMENT MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 16 NORTH AMERICA SERUM IN DANDRUFF TREATMENT MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 17 NORTH AMERICA HAIR MASK IN DANDRUFF TREATMENT MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 18 NORTH AMERICA MEDICATED IN DANDRUFF TREATMENT MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 19 NORTH AMERICA MEDICATED IN DANDRUFF TREATMENT MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 20 NORTH AMERICA SHAMPOO IN DANDRUFF TREATMENT MARKET (MEDICATED), BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 21 NORTH AMERICA ANTI-DANDRUFF SHAMPOOS IN DANDRUFF TREATMENT MARKET (MEDICATED), BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 22 NORTH AMERICA NORMAL SHAMPOOS IN DANDRUFF TREATMENT MARKET (MEDICATED), BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 23 NORTH AMERICA DRY SHAMPOOS IN DANDRUFF TREATMENT MARKET (MEDICATED), BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 24 NORTH AMERICA DANDRUFF TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)
TABLE 25 NORTH AMERICA BRANDED IN DANDRUFF TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 NORTH AMERICA GENERICS IN DANDRUFF TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 NORTH AMERICA DANDRUFF TREATMENT MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
TABLE 28 NORTH AMERICA ADULTS IN DANDRUFF TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 NORTH AMERICA PEDIATRICS IN DANDRUFF TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 30 NORTH AMERICA NEONATES IN DANDRUFF TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 31 NORTH AMERICA DANDRUFF TREATMENT MARKET, BY GENDER, 2019-2028 (USD MILLION)
TABLE 32 NORTH AMERICA MALE IN DANDRUFF TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 33 NORTH AMERICA FEMALE IN DANDRUFF TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 34 NORTH AMERICA DANDRUFF TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 35 NORTH AMERICA HOMECARE IN DANDRUFF TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 36 NORTH AMERICA DERMATOLOGY CENTERS IN DANDRUFF TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 37 NORTH AMERICA SPECIALTY CLINICS IN DANDRUFF TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 38 NORTH AMERICA OTHERS IN DANDRUFF TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 39 NORTH AMERICA DANDRUFF TREATMENT MARKET, BY DISTRIBUTION TYPE, 2019-2028 (USD MILLION)
TABLE 40 NORTH AMERICA SUPERMARKETS /HYPERMARKETS IN DANDRUFF TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 41 NORTH AMERICA CONVENIENCE STORES IN DANDRUFF TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 42 NORTH AMERICA PHARMACIES IN DANDRUFF TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 43 NORTH AMERICA RETAIL STORES IN DANDRUFF TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 44 NORTH AMERICA ONLINE STORES IN DANDRUFF TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 45 NORTH AMERICA OTHERS IN DANDRUFF TREATMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 46 NORTH AMERICA DANDRUFF TREATMENT MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 47 NORTH AMERICA DANDRUFF TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 48 NORTH AMERICA DANDRUFF TREATMENT MARKET, BY MODE OF PRESCRIPTION, 2019-2028 (USD MILLION)
TABLE 49 NORTH AMERICA DANDRUFF TREATMENT MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 50 NORTH AMERICA NON-MEDICATED IN DANDRUFF TREATMENT MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 51 NORTH AMERICA SHAMPOO IN DANDRUFF TREATMENT MARKET (NON-MEDICATED), BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 52 NORTH AMERICA ANTI-DANDRUFF SHAMPOOS IN DANDRUFF TREATMENT MARKET (NON-MEDICATED), BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 53 NORTH AMERICA NORMAL SHAMPOOS IN DANDRUFF TREATMENT MARKET (NON-MEDICATED), BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 54 NORTH AMERICA OILS IN DANDRUFF TREATMENT MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 55 NORTH AMERICA SERUM IN DANDRUFF TREATMENT MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 56 NORTH AMERICA HAIR MASK IN DANDRUFF TREATMENT MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 57 NORTH AMERICA MEDICATED IN DANDRUFF TREATMENT MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 58 NORTH AMERICA SHAMPOO IN DANDRUFF TREATMENT MARKET (MEDICATED), BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 59 NORTH AMERICA ANTI-DANDRUFF SHAMPOOS IN DANDRUFF TREATMENT MARKET (MEDICATED), BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 60 NORTH AMERICA DRY SHAMPOOS IN DANDRUFF TREATMENT MARKET (MEDICATED), BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 61 NORTH AMERICA NORMAL SHAMPOOS IN DANDRUFF TREATMENT MARKET (MEDICATED), BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 62 NORTH AMERICA DANDRUFF TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)
TABLE 63 NORTH AMERICA MEDICATED IN DANDRUFF TREATMENT MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
TABLE 64 NORTH AMERICA DANDRUFF TREATMENT MARKET, BY GENDER, 2019-2028 (USD MILLION)
TABLE 65 NORTH AMERICA DANDRUFF TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 66 NORTH AMERICA DANDRUFF TREATMENT MARKET, BY DISTRIBUTION TYPE, 2019-2028 (USD MILLION)
TABLE 67 U.S. DANDRUFF TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 68 U.S. DANDRUFF TREATMENT MARKET, BY MODE OF PRESCRIPTION, 2019-2028 (USD MILLION)
TABLE 69 U.S. DANDRUFF TREATMENT MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 70 U.S. NON-MEDICATED IN DANDRUFF TREATMENT MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 71 U.S. SHAMPOO IN DANDRUFF TREATMENT MARKET (NON-MEDICATED), BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 72 U.S. ANTI-DANDRUFF SHAMPOOS IN DANDRUFF TREATMENT MARKET (NON-MEDICATED), BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 73 U.S. NORMAL SHAMPOOS IN DANDRUFF TREATMENT MARKET (NON-MEDICATED), BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 74 U.S. OILS IN DANDRUFF TREATMENT MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 75 U.S. SERUM IN DANDRUFF TREATMENT MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 76 U.S. HAIR MASK IN DANDRUFF TREATMENT MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 77 U.S. MEDICATED IN DANDRUFF TREATMENT MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 78 U.S. SHAMPOO IN DANDRUFF TREATMENT MARKET (MEDICATED), BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 79 U.S. ANTI-DANDRUFF SHAMPOOS IN DANDRUFF TREATMENT MARKET (MEDICATED), BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 80 U.S. DRY SHAMPOOS IN DANDRUFF TREATMENT MARKET (MEDICATED), BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 81 U.S. NORMAL SHAMPOOS IN DANDRUFF TREATMENT MARKET (MEDICATED), BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 82 U.S. DANDRUFF TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)
TABLE 83 U.S. MEDICATED IN DANDRUFF TREATMENT MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
TABLE 84 U.S. DANDRUFF TREATMENT MARKET, BY GENDER, 2019-2028 (USD MILLION)
TABLE 85 U.S. DANDRUFF TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 86 U.S. DANDRUFF TREATMENT MARKET, BY DISTRIBUTION TYPE, 2019-2028 (USD MILLION)
TABLE 87 CANADA DANDRUFF TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 88 CANADA DANDRUFF TREATMENT MARKET, BY MODE OF PRESCRIPTION, 2019-2028 (USD MILLION)
TABLE 89 CANADA DANDRUFF TREATMENT MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 90 CANADA NON-MEDICATED IN DANDRUFF TREATMENT MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 91 CANADA SHAMPOO IN DANDRUFF TREATMENT MARKET (NON-MEDICATED), BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 92 CANADA ANTI-DANDRUFF SHAMPOOS IN DANDRUFF TREATMENT MARKET (NON-MEDICATED), BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 93 CANADA NORMAL SHAMPOOS IN DANDRUFF TREATMENT MARKET (NON-MEDICATED), BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 94 CANADA OILS IN DANDRUFF TREATMENT MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 95 CANADA SERUM IN DANDRUFF TREATMENT MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 96 CANADA HAIR MASK IN DANDRUFF TREATMENT MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 97 CANADA MEDICATED IN DANDRUFF TREATMENT MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 98 CANADA SHAMPOO IN DANDRUFF TREATMENT MARKET (MEDICATED), BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 99 CANADA ANTI-DANDRUFF SHAMPOOS IN DANDRUFF TREATMENT MARKET (MEDICATED), BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 100 CANADA DRY SHAMPOOS IN DANDRUFF TREATMENT MARKET (MEDICATED), BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 101 CANADA NORMAL SHAMPOOS IN DANDRUFF TREATMENT MARKET (MEDICATED), BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 102 CANADA DANDRUFF TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)
TABLE 103 CANADA MEDICATED IN DANDRUFF TREATMENT MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
TABLE 104 CANADA DANDRUFF TREATMENT MARKET, BY GENDER, 2019-2028 (USD MILLION)
TABLE 105 CANADA DANDRUFF TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 106 CANADA DANDRUFF TREATMENT MARKET, BY DISTRIBUTION TYPE, 2019-2028 (USD MILLION)
TABLE 107 MEXICO DANDRUFF TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 108 MEXICO DANDRUFF TREATMENT MARKET, BY MODE OF PRESCRIPTION, 2019-2028 (USD MILLION)
TABLE 109 MEXICO DANDRUFF TREATMENT MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 110 MEXICO NON-MEDICATED IN DANDRUFF TREATMENT MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 111 MEXICO SHAMPOO IN DANDRUFF TREATMENT MARKET (NON-MEDICATED), BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 112 MEXICO ANTI-DANDRUFF SHAMPOOS IN DANDRUFF TREATMENT MARKET (NON-MEDICATED), BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 113 MEXICO NORMAL SHAMPOOS IN DANDRUFF TREATMENT MARKET (NON-MEDICATED), BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 114 MEXICO OILS IN DANDRUFF TREATMENT MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 115 MEXICO SERUM IN DANDRUFF TREATMENT MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 116 MEXICO HAIR MASK IN DANDRUFF TREATMENT MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 117 MEXICO MEDICATED IN DANDRUFF TREATMENT MARKET, BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 118 MEXICO SHAMPOO IN DANDRUFF TREATMENT MARKET (MEDICATED), BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 119 MEXICO ANTI-DANDRUFF SHAMPOOS IN DANDRUFF TREATMENT MARKET (MEDICATED), BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 120 MEXICO DRY SHAMPOOS IN DANDRUFF TREATMENT MARKET (MEDICATED), BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 121 MEXICO NORMAL SHAMPOOS IN DANDRUFF TREATMENT MARKET (MEDICATED), BY PRODUCT, 2019-2028 (USD MILLION)
TABLE 122 MEXICO DANDRUFF TREATMENT MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)
TABLE 123 MEXICO MEDICATED IN DANDRUFF TREATMENT MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
TABLE 124 MEXICO DANDRUFF TREATMENT MARKET, BY GENDER, 2019-2028 (USD MILLION)
TABLE 125 MEXICO DANDRUFF TREATMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 126 MEXICO DANDRUFF TREATMENT MARKET, BY DISTRIBUTION TYPE, 2019-2028 (USD MILLION)
그림 목록
LIST OF FIGURES
FIGURE 1 NORTH AMERICA DANDRUFF TREATMENT MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA DANDRUFF TREATMENT MARKET : DATA TRIANGULATION
FIGURE 3 NORTH AMERICA DANDRUFF TREATMENT MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA DANDRUFF TREATMENT MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA DANDRUFF TREATMENT MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA DANDRUFF TREATMENT MARKET: MULTIVARIATE MODELLING
FIGURE 7 NORTH AMERICA DANDRUFF TREATMENT MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 NORTH AMERICA DANDRUFF TREATMENT MARKET: DBMR MARKET POSITION GRID
FIGURE 9 NORTH AMERICA DANDRUFF TREATMENT MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA IS EXPECTED TO DOMINATE AND ASIA-PACIFIC IS GROWING AT THE FASTEST PACE IN THE NORTH AMERICA DANDRUFF TREATMENT MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 11 INCREASING NUMBER OF MALASSEZIA SPECIES IN ENVIRONMENT AND INCREASING PREVALENCE OF HIV ARE DRIVING THE NORTH AMERICA DANDRUFF TREATMENT MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 FUNGAL DANDRUFF TREATMENT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA DANDRUFF TREATMENT MARKET IN 2021 & 2028
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF NORTH AMERICA DANDRUFF TREATMENT MARKET
FIGURE 14 HIV INFECTION IN 2018 ACROSS DIFFERENT REGIONS OF WORLD
FIGURE 15 PERCENTAGE OF INTERNET USERS IN 2016 AND 2019
FIGURE 16 NORTH AMERICA DANDRUFF TREATMENTMARKET: BY TYPE, 2020
FIGURE 17 NORTH AMERICA DANDRUFF TREATMENTMARKET: BY TYPE, 2020-2028 (USD MILLION)
FIGURE 18 NORTH AMERICA DANDRUFF TREATMENTMARKET: BY TYPE, CAGR (2021-2028)
FIGURE 19 NORTH AMERICA DANDRUFF TREATMENTMARKET: BY TYPE, LIFELINE CURVE
FIGURE 20 NORTH AMERICA DANDRUFF TREATMENTMARKET: BY MODE OF PRESCRIPTION, 2020
FIGURE 21 NORTH AMERICA DANDRUFF TREATMENTMARKET: BY MODE OF PRESCRIPTION, 2020-2028 (USD MILLION)
FIGURE 22 NORTH AMERICA DANDRUFF TREATMENTMARKET: BY MODE OF PRESCRIPTION, CAGR (2021-2028).
FIGURE 23 NORTH AMERICA DANDRUFF TREATMENTMARKET: BY MODE OF PRESCRIPTION, LIFELINE CURVE
FIGURE 24 NORTH AMERICA DANDRUFF TREATMENT MARKET: BY TYPE, 2020
FIGURE 25 NORTH AMERICA DANDRUFF TREATMENT MARKET: BY TYPE, 2020-2028 (USD MILLION)
FIGURE 26 NORTH AMERICA DANDRUFF TREATMENT MARKET: BY TYPE, CAGR (2021-2028)
FIGURE 27 NORTH AMERICA DANDRUFF TREATMENT MARKET: BY TYPE, LIFELINE CURVE
FIGURE 28 NORTH AMERICA DANDRUFF TREATMENTMARKET: BY DRUG TYPE, 2020
FIGURE 29 NORTH AMERICA DANDRUFF TREATMENTMARKET: BY DRUG TYPE, 2020-2028 (USD MILLION)
FIGURE 30 NORTH AMERICA DANDRUFF TREATMENTMARKET: BY DRUG TYPE, CAGR (2021-2028)
FIGURE 31 NORTH AMERICA DANDRUFF TREATMENTMARKET: BY DRUG TYPE, LIFELINE CURVE
FIGURE 32 NORTH AMERICA DANDRUFF TREATMENTMARKET: BY AGE GROUP, 2020
FIGURE 33 NORTH AMERICA DANDRUFF TREATMENTMARKET: BY AGE GROUP, 2020-2028 (USD MILLION)
FIGURE 34 NORTH AMERICA DANDRUFF TREATMENTMARKET: BY AGE GROUP, CAGR (2021-2028)
FIGURE 35 NORTH AMERICA DANDRUFF TREATMENTMARKET: BY AGE GROUP, LIFELINE CURVE
FIGURE 36 NORTH AMERICA DANDRUFF TREATMENTMARKET: BY GENDER, 2020
FIGURE 37 NORTH AMERICA DANDRUFF TREATMENTMARKET: BY GENDER, 2020-2028 (USD MILLION)
FIGURE 38 NORTH AMERICA DANDRUFF TREATMENTMARKET: BY GENDER, CAGR (2021-2028)
FIGURE 39 NORTH AMERICA DANDRUFF TREATMENTMARKET: BY GENDER, LIFELINE CURVE
FIGURE 40 NORTH AMERICA DANDRUFF TREATMENT MARKET: BY END USER, 2020
FIGURE 41 NORTH AMERICA DANDRUFF TREATMENT MARKET: BY END USER, 2020-2028 (USD MILLION)
FIGURE 42 NORTH AMERICA DANDRUFF TREATMENT MARKET: BY END USER, CAGR (2021-2028)
FIGURE 43 NORTH AMERICA DANDRUFF TREATMENT MARKET: BY END USER, LIFELINE CURVE
FIGURE 44 NORTH AMERICA DANDRUFF TREATMENTMARKET: BY DISTRIBUTION TYPE, 2020
FIGURE 45 NORTH AMERICA DANDRUFF TREATMENTMARKET: BY DISTRIBUTION TYPE, 2020-2028 (USD MILLION)
FIGURE 46 NORTH AMERICA DANDRUFF TREATMENTMARKET: BY DISTRIBUTION TYPE, CAGR (2021-2028)
FIGURE 47 NORTH AMERICA DANDRUFF TREATMENTMARKET: BY DISTRIBUTION TYPE, LIFELINE CURVE
FIGURE 48 NORTH AMERICA DANDRUFF TREATMENT MARKET: SNAPSHOT (2020)
FIGURE 49 NORTH AMERICA DANDRUFF TREATMENT MARKET: BY COUNTRY (2020)
FIGURE 50 NORTH AMERICA DANDRUFF TREATMENT MARKET: BY COUNTRY (2021 & 2028)
FIGURE 51 NORTH AMERICA DANDRUFF TREATMENT MARKET: BY COUNTRY (2020 & 2028)
FIGURE 52 NORTH AMERICA DANDRUFF TREATMENT MARKET: BY TYPE (2021-2028)
FIGURE 53 NORTH AMERICA DANDRUFF TREATMENT MARKET: COMPANY SHARE 2020 (%)
FIGURE 54 EUROPE DANDRUFF TREATMENT MARKET: COMPANY SHARE 2020 (%)
FIGURE 55 ASIA-PACIFIC DANDRUFF TREATMENT MARKET: COMPANY SHARE 2020 (%)
연구 방법론
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.
DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.
사용자 정의 가능
Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.
